Disclaimer:All content on this platform is sourced from the internet and is provided for informational purposes only. None of the content represents the views of this site, nor does it constitute investment advice. Please exercise caution when investing.
Hong Kong-listed innovative drug stocks gained ground, with Tongyuan Kang Pharmaceutical rising more than 7%, while Lepu Bio, Shijiazhuang Pharmaceutical Group, and CanSino Biologics each rose more than 3%, and Kelun Botai Biologics and Hansoh Pharmaceutical each rose more than 2%.
Hong Kong-listed innovative drug stocks gained ground, with Tongyuan Kang Pharmaceutical rising more than 7%, while Lepu Bio, Shijiazhuang Pharmaceutical Group, and CanSino Biologics each rose more than 3%, and Kelun Biotech and Hansoh Pharmaceutical each rose more than 2%.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice. If you find any violations, please Click to Report
Recommended Reading


